[Antifungal agent resistance of yeasts of clinical significance].
Odds
F C
FC
Departamento de Bacteriología y Micología, Janssen Research Foundation, Bélgica.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000935:Antifungal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001393:Azoles / Q000494:pharmacology; D002176:Candida albicans / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy; D004352:Drug Resistance, Microbial; D015725:Fluconazole / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D017964:Itraconazole / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D007654:Ketoconazole / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D009181:Mycoses / Q000188:drug therapy; D015003:Yeasts / Q000187:drug effects*
D000935:Antifungal Agents; D001393:Azoles; D017964:Itraconazole; D015725:Fluconazole; D007654:Ketoconazole